Oppenheimer Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 13 21:31 · Ratings

Stifel Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 13 21:31 · Ratings

JonesTrading Maintains Oric Pharmaceuticals(ORIC.US) With Buy Rating, Maintains Target Price $17

Futu NewsNov 13 06:31 · Ratings

Promising Advancements in Cancer Treatment: Buy Rating for ORIC Pharmaceuticals

TipRanksNov 13 06:15 · Ratings

Oric Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 13 05:27 · Announcements

Express News | Oric Pharmaceuticals Inc: Cash and Investments of $282.4 Mln Expected to Fund Operating Plan Into Late 2026

BreakingsNov 13 05:17